Safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a …
R González, T Nhampossa… - The Lancet Infectious …, 2024 - thelancet.com
Background The cornerstone of malaria prevention in pregnancy, intermittent preventive
treatment (IPTp) with sulfadoxine–pyrimethamine, is contraindicated in women with HIV who …
treatment (IPTp) with sulfadoxine–pyrimethamine, is contraindicated in women with HIV who …
Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin–piperaquine in pregnant women living with HIV on daily co …
HC Barsosio, M Madanitsa, ED Ondieki, J Dodd… - The Lancet, 2024 - thelancet.com
Background The efficacy of daily co-trimoxazole, an antifolate used for malaria
chemoprevention in pregnant women living with HIV, is threatened by cross-resistance of …
chemoprevention in pregnant women living with HIV, is threatened by cross-resistance of …
Impact of dolutegravir-based antiretroviral therapy on piperaquine exposure following dihydroartemisinin-piperaquine intermittent preventive treatment of malaria in …
Dihydroartemisinin-piperaquine, an artemisinin-based combination therapy, has been
identified as a promising agent for intermittent preventive treatment of malaria in pregnancy …
identified as a promising agent for intermittent preventive treatment of malaria in pregnancy …
Dihydroartemisinin–piperaquine for prevention of malaria in pregnant women living with HIV
Prevention of malaria during pregnancy is crucial to avoid the consequences of malaria
infection, which include preterm birth, fetal loss, low birthweight, small for gestational age …
infection, which include preterm birth, fetal loss, low birthweight, small for gestational age …